We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
-$159M
(-1.2%)
Cap. Flow
+$1.08B
Cap. Flow
% of AUM
8.52%
Top 10 Holdings %
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$63.1M |
| 2 |
WW
WW International
WW
|
+$57.1M |
| 3 |
Hexcel
HXL
|
+$57.1M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$54.4M |
| 5 |
HealthEquity
HQY
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$70.3M |
| 2 |
WCN
Waste Connections
WCN
|
+$61.3M |
| 3 |
Acuity Brands
AYI
|
+$56.2M |
| 4 |
JetBlue
JBLU
|
+$54.3M |
| 5 |
Martin Marietta Materials
MLM
|
+$53.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.28% |
| 2 | Technology | 18.45% |
| 3 | Industrials | 14.15% |
| 4 | Consumer Discretionary | 14.07% |
| 5 | Financials | 10.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Protolabs
PRLB
$1.7B
| $7.2M | 0.06% |
60,526
-974
| -2% | -$119K |
|
352
Semtech
SMTC
$9.65B
| $7.19M | 0.06% |
152,896
+772
| +0.5% | +$34.6K |
|
353
Thermo Fisher Scientific
TMO
$214B
| $7.19M | 0.06% |
+34,700
| New | +$7.37M |
|
|
STI
354
DELISTED
SunTrust Banks, Inc.
STI
| $6.84M | 0.05% |
103,625
-337,425
| -77% | -$22.9M |
|
355
AbbVie
ABBV
$465B
| $6.77M | 0.05% |
+73,100
| New | +$7.14M |
|
356
Northrop Grumman
NOC
$76B
| $6.74M | 0.05% |
+21,900
| New | +$7.24M |
|
|
BEAT
357
DELISTED
BioTelemetry, Inc.
BEAT
| $6.73M | 0.05% |
149,604
-2,496
| -2% | -$99.5K |
|
358
Ziff Davis
ZD
$2B
| $6.71M | 0.05% |
89,150
-1,528
| -2% | -$112K |
|
|
CARB
359
DELISTED
Carbonite Inc
CARB
| $6.33M | 0.05% |
181,474
-3,426
| -2% | -$118K |
|
360
NetApp
NTAP
$34B
| $6.3M | 0.05% |
+80,200
| New | +$5.64M |
|
361
AMN Healthcare
AMN
$1.35B
| $6.12M | 0.05% |
104,403
-1,747
| -2% | -$104K |
|
362
D.R. Horton
DHI
$41.2B
| $6.11M | 0.05% |
149,000
+44,375
| +42% | +$1.91M |
|
363
Monro
MNRO
$414M
| $5.91M | 0.05% |
101,683
-1,467
| -1% | -$82.8K |
|
|
AET
364
DELISTED
Aetna Inc
AET
| $5.89M | 0.05% |
+32,100
| New | +$5.72M |
|
|
GRMN
365
Garmin
GRMN
$56.9B
| $5.84M | 0.05% |
95,700
-69,600
| -42% | -$4.18M |
|
366
Lam Research
LRCX
$316B
| $5.75M | 0.05% |
333,000
-181,500
| -35% | -$3.5M |
|
367
KeyCorp
KEY
$23.8B
| $5.72M | 0.05% |
292,725
-648,525
| -69% | -$12.9M |
|
368
Labcorp
LH
$25.2B
| $5.64M | 0.04% |
36,550
-8,142
| -18% | -$1.23M |
|
|
ETFC
369
DELISTED
E*Trade Financial Corporation
ETFC
| $5.45M | 0.04% |
+89,100
| New | +$5.52M |
|
|
BCPC
370
Balchem Corp
BCPC
$5.26B
| $5.44M | 0.04% |
55,465
+285
| +0.5% | +$26.6K |
|
371
Performance Food Group
PFGC
$18.3B
| $5.4M | 0.04% |
147,033
-1,942
| -1% | -$65.7K |
|
|
SKX
372
DELISTED
Skechers
SKX
| $5.37M | 0.04% |
179,025
+3,325
| +2% | +$106K |
|
373
LyondellBasell Industries
LYB
$19.5B
| $5.32M | 0.04% |
+48,400
| New | +$5.31M |
|
|
XLNX
374
DELISTED
Xilinx Inc
XLNX
| $5.27M | 0.04% |
80,725
-36,925
| -31% | -$2.52M |
|
375
Simon Property Group
SPG
$76.4B
| $5.22M | 0.04% |
30,678
-525
| -2% | -$83.5K |
|
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q2 2018 Portfolio in Review
As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.
- Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
- Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
- Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
- Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
- Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
- Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
- Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.
Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.